Powered By
Taken from the recently published book by Dr. Peter Attia, “Outlive: The Science and Art of Longevity, the FDA has given approval for a clinical trial of the popular diabetes drug, Metformin, for it’s potential longevity benefits. The trial is called TAME (Targeting Aging with Metformin). Metformin has been taken by millions of people for years. Over time, researchers noticed (and studies appeared to confirm) that patients on metformin appeared to have a lower incidence of cancer than the… read more
Sounds like an interesting study
And I have heard the part about cancer incidence in diabetics before. It is well documented that Diabetics get cancer at a much lower rate then the general public
This could be part of the reason????? (maybe the study can answer that)
I agree interesting study. Anxious to see results.
I have been on Metformin for 22-23 years with no apparent ill effects.
Join
Your Privacy Choices
